The Board of Directors of NESTMEDIC SA, a joint-stock company, with its registered office in Wrocław (the “Company”), in response to the shareholders’ questions concerning the stock held by the Company employees and the lock-up restrictions, announces that the Board members, i.e. Ms. Patrycja Wizińska-Socha as of the day of the IPO (see e.g. Information Document, p. 167) and as of the day of the EGM held on July 12, 2017 (ESPI 4/2017) was in possession of 1,350,000 company stock. Ms. Anna Skotny, a co-founder, (the same sources) had 300,000 stock at both dates. According to the best knowledge of Company’s the other employees of the Company bought the stock only under the private placement offer (before the IPO). During the private placement offer the company employees bought the stock for PLN 12 per share.
Additionally, on page 31 ( 5.1.3.6.) of the Information Document, “Restrictions Arising from Contractual Obligations”, it is indicated that the contractual lock-up provisions (concerning shareholders’ obligation not to dispose of the Series A stock for a period of twelve months following the admission of the Issuer’s stock to the Exchange trading) referred to 3,623,500 Series A stock. Moreover, the stock held by Nestmedic ESOP Sp. z o.o., i.e. 500,000 Series A stock, which are not included in the lock-up agreements as of the date of the Information Document, will be awarded to the key employees of the Company under the bonus scheme or long-term management programs to be implemented in 2017-2020. The Company’s intension is that the stock awarded under the Management Stock Option Program continues to be subject to contractual lock-up on the Exchange.
Legal basis: § 4 (2)(12) of Exhibit 3 to the Alternative Trading System Rules “Current and Periodical Information in the Alternative Trading System on the NewConnect Market”
